Do viruses cause inner ear disturbances?

ORL

Volumn 70, Issue 1, 2008, Pages 32-40

  Pyykko I ^a,c   Kentala, E ^b   Zou, J ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Coinfection; Herpes zoster virus; Influenza virus; Latent infection; Viral receptors

Indexed keywords

ACICLOVIR; CIDOFOVIR; GANCICLOVIR; HYDROCORTISONE; PREDNISONE; VALACICLOVIR;

ANTIVIRAL THERAPY; ARTICLE; BINDING AFFINITY; COCHLEAR NERVE; CORRELATION ANALYSIS; DRUG EFFICACY; HEARING LOSS; HUMAN; INFLUENZA VIRUS B; INNER EAR DISEASE; MENIERE DISEASE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RODENT; SEROLOGY; VARICELLA ZOSTER VIRUS; VERTIGO; VIRUS; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA, VIRAL; ENTEROVIRUS B, HUMAN; FEMALE; FOLLOW-UP STUDIES; GENICULATE GANGLION; HEARING LOSS, SUDDEN; HERPESVIRUS 3, HUMAN; HUMANS; INCIDENCE; INFLUENZA B VIRUS; LABYRINTH DISEASES; MALE; MENIERE DISEASE; MIDDLE AGED; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VERTIGO; VESTIBULAR NERVE;

EID: 38849192360     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111046     Document Type: Article

References (89)

1. Schuknecht HF, Suzuka Y, Zimmermann C: Delayed endolymphatic hydrops and its relationship to Ménière's disease. Ann Otol Rhinol Laryngol 1990;99:843-853.
2. Hyden D, Akerlind B, Peebo M: Inner ear and facial nerve complications of acute otitis media with focus on bacteriology and virology. Acta Otolaryngol 2006;126:460-466.
3. Davis LE, Rarey KE, McLaren LC: Clinical viral infections and temporal bone histologic studies of patients with AIDS. Otolaryngol Head Neck Surg 1995;113:695-701.
4. Sugiura S, Yoshikawa T, Nishiyama Y, et al: Detection of herpesvirus DNAs in perilymph obtained from patients with sensorineural hearing loss by real-time polymerase chain reaction. Laryngoscope 2004;114:2235-2238.
5. Davis GL, Spector GJ, Strauss M, Middlekamp JN: Cytomegalovirus endolabyrinthitis. Arch Pathol Lab Med 1977;101:118-121.
6. Arbusow V, Theil D, Strupp M, Mascolo A, Brandt T: HSV-1 not only in human vestibular ganglia but also in the vestibular labyrinth. Audiol Neurootol 2001;6:259-262.
7. Welling DB, Miles BA, Western L, Prior TW: Detection of viral DNA in vestibular ganglia tissue from patients with Ménière's disease. Am J Otol 1997;18:734-737.
8. Cotter CS, Singleton GT, Corman LC: Immune-mediated inner ear disease and parvovirus B19. Laryngoscope 1994;104:1235-1239.
9. Fujinami RS: Viruses and autoimmune disease - two sides of the same coin? Trends Microbiol 2001;9:377-381.
10. Rouse BT, Deshpande S: Viruses and autoimmunity: an affair but not a marriage contract. Rev Med Virol 2002;12:107-113.
11. Fujinami RS, Oldstone MB: Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985;230:1043-1045.
12. Czarneski J, Rassa JC, Ross SR: Mouse mammary tumor virus and the immune system. Immunol Res 2003;27:469-480.
13. Sicat J, Sutkowski N, Huber BT: Expression of human endogenous retrovirus HERV-K18 superantigen is elevated in juvenile rheumatoid arthritis. J Rheumatol 2005;32:1821-1831.
14. Davis LE: Comparative experimental viral labyrinthitis. Am J Otolaryngol 1990;11:382-388.
15. Luebke AE, Foster PK, Muller CD, Peel AL: Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer. Hum Gene Ther 2001;12:773-781.
16. Luebke AE, Steiger JD, Hodges BL, Amalfitano A: A modified adenovirus can transfect cochlear hair cells in vivo without compromising cochlear function. Gene Ther 2001;8:789-794.
17. Tamura M, Ogino S, Matsunaga T, et al: Experimental labyrinthitis in rats caused by infecting with virus causing hemorrhagic fever with renal syndrome (HFRS). Acta Otolaryngol 1989;108:19-25.
18. Tamura M, Ogino S, Matsunaga T, et al: Experimental labyrinthitis in guinea pigs caused by a hantavirus. ORL J Otorhinolaryngol Relat Spec 1991;53:1-5.
19. Harris JP, Fan JT, Keithley EM: Immunologic responses in experimental cytomegalovirus labyrinthitis. Am J Otolaryngol 1990;11:304-308.
20. Woolf NK, Koehrn FJ, Harris JP, Richman DD: Congenital cytomegalovirus labyrinthitis and sensorineural hearing loss in guinea pigs. J Infect Dis 1989;160:929-937.
21. Nomura Y, Hara M, Kurata T: Experimental herpes simplex virus and cytomegalovirus labyrinthitis. Acta Otolaryngol Suppl 1989;457:57-66.
22. Falser N, Bandtlow I, Rziha HJ, Haus M, Wolf H: The role of acute and latent virus infections in the pathogenesis of inner ear disturbances. Am J Otol 1987;8:136-147.
23. Rarey KE, Rush NL, Davis JA, Deshmukh DR: Altered auditory brainstem evoked responses in the ferret model for Reye's syndrome. Int J Pediatr Otorhinolaryngol 1984;7:221-228.
24. Zhong GY: Ultrastructural changes in middle ear and cochlea caused by respiratory syncytial virus in guinea pigs (in Chinese). Zhonghua Er Bi Yan Hou Ke Za Zhi 1990;25:213-215, 255.
25. Tanaka K, Fukuda S, Terayama Y, et al: Experimental mumps labyrinthitis in monkeys (Macaca irus) - immunohistochemical and ultrastructural studies. Auris Nasus Larynx 1988;15:89-96.
26. Davis LE, Johnson RT: Experimental viral infections of the inner ear. I. Acute infections of the newborn hamster labyrinth. Lab Invest 1976;34:349-356.
27. Bewley MC, Springer K, Zhang YB, Freimuth P, Flanagan JM: Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. Science 1999;286:1579-1583.
28. He Y, Chipman PR, Howitt J, et al: Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat Struct Biol 2001;8:874-878.
29. Bruning A, Runnebaum IB: The coxsackie adenovirus receptor inhibits cancer cell migration. Exp Cell Res 2004;298:624-631.
30. Coyne CB, Bergelson JM: CAR: a virus receptor within the tight junction. Adv Drug Deliv Rev 2005;57:869-882.
31. Excoffon KJ, Hruska-Hageman A, Klotz M, Traver GL, Zabner J: A role for the PDZ-binding domain of the coxsackie B virus and adenovirus receptor (CAR) in cell adhesion and growth. J Cell Sci 2004;117:4401-4409.
32. Okegawa T, Pong RC, Li Y, Bergelson JM, Sagalowsky AI, Hsieh JT: The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure. Cancer Res 2001;61:6592-6600.
33. Asher DR, Cerny AM, Weiler SR, et al: Coxsackievirus and adenovirus receptor is essential for cardiomyocyte development. Genesis 2005;42:77-85.
34. Dorner AA, Wegmann F, Butz S, et al: Coxsackievirus-adenovirus receptor (CAR) is essential for early embryonic cardiac development. J Cell Sci 2005;118:3509-3521.
35. Venail F, Wang J, Ruel J, et al: Coxsackie adenovirus receptor and alpha nu beta3/alpha nu beta5 integrins in adenovirus gene transfer of rat cochlea. Gene Ther 2007;14:30-37.
36. Ishimoto S, Kawamoto K, Kanzaki S, Raphael Y: Gene transfer into supporting cells of the organ of Corti. Hear Res 2002;173:187-197.
37. Izumikawa M, Minoda R, Kawamoto K, et al: Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med 2005;11:271-276.
38. Bergelson JM, Cunningham JA, Droguett G, et al: Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997;275:1320-1323.
39. Nemerow GR, Stewart PL: Role of alpha(v) integrins in adenovirus cell entry and gene delivery. Microbiol Mol Biol Rev 1999;63:725-734.
40. Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh JT, Bergelson JM: The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci USA 2001;98:15191-15196.
41. Walters RW, Freimuth P, Moninger TO, Ganske I, Zabner J, Welsh MJ: Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape. Cell 2002;110:789-799.
42. Dechecchi MC, Tamanini A, Bonizzato A, Cabrini G: Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology 2000;268:382-390.
43. Rogers GN, Paulson JC, Daniels RS, Skehel JJ, Wilson IA, Wiley DC: Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 1983;304:76-78.
44. Doms RW, Helenius A: Quaternary structure of influenza virus hemagglutinin after acid treatment. J Virol 1986;60:833-839.
45. Imai M, Mizuno T, Kawasaki K: Membrane fusion by single influenza hemagglutinin trimers. Kinetic evidence from image analysis of hemagglutinin-reconstituted vesicles. J Biol Chem 2006;281:12729-12735.
46. Skehel JJ, Wiley DC: Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 2000;69:531-569.
47. Rust MJ, Lakadamyali M, Zhang F, Zhuang X: Assembly of endocytic machinery around individual influenza viruses during viral entry. Nat Struct Mol Biol 2004;11:567-573.
48. Shukla D, Spear PG: Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J Clin Invest 2001;108:503-510.
49. Nicola AV, McEvoy AM, Straus SE: Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J Virol 2003;77:5324-5332.
50. Nicola AV, Straus SE: Cellular and viral requirements for rapid endocytic entry of herpes simplex virus. J Virol 2004;78:7508-7517.
51. Tsuprun V, Santi P: Proteoglycan arrays in the cochlear basement membrane. Hear Res 2001;157:65-76.
52. Derby ML, Sena-Esteves M, Breakefield XO, Corey DP: Gene transfer into the mammalian inner ear using HSV-1 and vaccinia virus vectors. Hear Res 1999;134:1-8.
53. Wang JP, Kurt-Jones EA, Shin OS, Manchak MD, Levin MJ, Finberg RW: Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2. J Virol 2005;79:12658-12666.
54. Kramer MF, Cook WJ, Roth FP, et al: Latent herpes simplex virus infection of sensory neurons alters neuronal gene expression. J Virol 2003;77:9533-9541.
55. Thomas SK, Lilley CE, Latchman DS, Coffin RS: A protein encoded by the herpes simplex virus (HSV) type 1 2-kilobase latency-associated transcript is phosphorylated, localized to the nucleus, and overcomes the repression of expression from exogenous promoters when inserted into the quiescent HSV genome. J Virol 2002;76:4056-4067.
56. Danaher RJ, Jacob RJ, Steiner MR, Allen WR, Hill JM, Miller CS: Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells. J Neurovirol 2005;11:306-317.
57. Kumagami H: Detection of viral antigen in the endolymphatic sac. Eur Arch Otorhinolaryngol 1996;253:264-267.
58. Furuta Y, Takasu T, Suzuki S, Fukuda S, Inuyama Y, Nagashima K: Detection of latent varicella-zoster virus infection in human vestibular and spiral ganglia. J Med Virol 1997;51:214-216.
59. Yazawa Y, Suzuki M, Hanamitsu M, Kimura H, Tooyama I: Detection of viral DNA in the endolymphatic sac in Ménière's disease by in situ hybridization. ORL J Otorhinolaryngol Relat Spec 2003;65:162-168.
60. Vrabec JT: Herpes simplex virus and Ménière's disease. Laryngoscope 2003;113:1431-1438.
61. Woolf NK, Ochi JW, Silva EJ, Sharp PA, Harris JP, Richman DD: Ganciclovir prophylaxis for cochlear pathophysiology during experimental guinea pig cytomegalovirus labyrinthitis. Antimicrob Agents Chemother 1988;32:865-872.
62. Stokroos RJ, Albers FW, Tenvergert EM: Antiviral treatment of idiopathic sudden sensorineural hearing loss: a prospective, randomized, double-blind clinical trial. Acta Otolaryngol 1998;118:488-495.
63. White DR, Choo DI, Stroup G, Schleiss MR: The effect of cidofovir on cytomegalovirusinduced hearing loss in a Guinea pig model. Arch Otolaryngol Head Neck Surg 2006;132:608-615.
64. Nigro G, Scholz H, Bartmann U: Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience. J Pediatr 1994;124:318-322.
65. Schleiss MR, McVoy MA: Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy. Expert Rev Anti Infect Ther 2004;2:389-403.
66. Tanaka-Kitajima N, Sugaya N, Futatani T, et al: Ganciclovir therapy for congenital cytomegalovirus infection in six infants. Pediatr Infect Dis J 2005;24:782-785.
67. Stokroos RJ, Albers FW, Schirm J: Therapy of idiopathic sudden sensorineural hearing loss: antiviral treatment of experimental herpes simplex virus infection of the inner ear. Ann Otol Rhinol Laryngol 1999;108:423-428.
68. Bramley AM, Khan MA, Manson HE, Hegele RG: Development of respiratory syncytial virus 'bronchiolitis' in guinea pigs does not reflect an allergic predisposition in the host. Chest 2003;124:671-681.
69. Kaufmann P, Davidoff M: The guinea-pig placenta. Adv Anat Embryol Cell Biol 1977;53:5-91.
70. Leiser R, Kaufmann P: Placental structure: in a comparative aspect. Exp Clin Endocrinol 1994;102:122-134.
71. Hirai T: Effect of steroid hormone on experimental viral labyrinthitis in guinea pigs (in Japanese). Hokkaido Igaku Zasshi 1991;66:625-638.
72. Strupp M, Zingler VC, Arbusow V, et al: Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med 2004;351:354-361.
73. Westerlaken BO, Stokroos RJ, Dhooge IJ, Wit HP, Albers FW: Treatment of idiopathic sudden sensorineural hearing loss with antiviral therapy: a prospective, randomized, double-blind clinical trial. Ann Otol Rhinol Laryngol 2003;112:993-1000.
74. Tucci DL, Farmer JC Jr, Kitch RD, Witsell DL: Treatment of sudden sensorineural hearing loss with systemic steroids and valacyclovir. Otol Neurotol 2002;23:301-308.
75. Uri N, Doweck I, Cohen-Kerem R, Greenberg E: Acyclovir in the treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2003;128:544-549.
76. Tenser RB: Methylprednisolone, valacyclovir, or both for vestibular neuritis. N Engl J Med 2004;351:2344-2345; author reply 2344-2345.
77. Veltri RW, Wilson WR, Sprinkle PM, Rodman SM, Kavesh DA: The implication of viruses in idiopathic sudden hearing loss: primary infection or reactivation of latent viruses? Otolaryngol Head Neck Surg 1981;89:137-141.
78. Bergström T, Edström S, Tjellström A, Vahlne A: Ménière's disease and antibody reactivity to herpes simplex virus type 1 polypeptides. Am J Otolaryngol 1992;13:295-300.
79. Wilmes EH, Roggendorf M: Viral infection and sudden perceptive deafness (serological examinations) (author's transl). Laryngol Rhinol Otol (Stuttg) 1979;58:817-821.
80. Feldman LT, Ellison AR, Voytek CC, Yang L, Krause P, Margolis TP: Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci USA 2002;99:978-983.
81. Welling DB, Daniels RL, Brainard J, Western LM, Prior TW: Detection of viral DNA in endolymphatic sac tissue from Ménière's disease patients. Am J Otol 1994;15:639-643.
82. Altermatt HJ, Gebbers JO, Muller C, Arnold W, Laissue JA: Human endolymphatic sac: evidence for a role in inner ear immune defence. ORL J Otorhinolaryngol Relat Spec 1990;52:143-148.
83. Arenberg IK, Obert AD, Gibson WP: Intraoperative electrocochleographic monitoring of inner ear surgery for endolymphatic hydrops. A review of cases. Acta Otolaryngol Suppl 1991;485:53-64.
84. McCabe BF: Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979;88:585-589.
85. Harris JP, Sharp PA: Inner ear autoantibodies in patients with rapidly progressive sensorineural hearing loss. Laryngoscope 1990;100:516-524.
86. Soliman AM: Immune-mediated inner ear disease. Am J Otol 1992;13:575-579.
87. Gottschlich S, Billings PB, Keithley EM, Weisman MH, Harris JP: Assessment of serum antibodies in patients with rapidly progressive sensorineural hearing loss and Ménière's disease. Laryngoscope 1995;105:1347-1352.
88. Harris JP, Aframian D: Role of autoimmunity in contralateral delayed endolymphatic hydrops. Am J Otol 1994;15:710-716.
89. Divito S CT, Hendricks RL: A triple entente: virus, neurons, and CD8+ T cells maintain HSV-1 latency. Immunol Res 2006;36:119-126.